CLASS III Device recall · Reported 21 Sep 2016 · FDA Enforcement Report

Vidas NT-pro-BNP recalled by Biomerieux France Chemin De

Biomerieux France Chemin De L'Or is recalling Vidas NT-pro-BNP, distributed nationwide in the US. The recall was initiated on 15 Apr 2016 and the FDA has classified it as Class III.

Check your package

Lot, batch or date codesReference number: 30449-01, Lot #1004474560.
Quantity recalled229 kits

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-2779-2016
FDA event ID
73989
Recalling firm
Biomerieux France Chemin De L'Or, Marcy L'Etoile, N/A
Classification
Class III
Status
Terminated
Recall initiated
15 Apr 2016
FDA classified
9 Sep 2016
Reported
21 Sep 2016
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Packaging Defects

Timeline

15 Apr 2016Recall initiated by company
9 Sep 2016Classified by FDA+147 days
21 Sep 2016Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Due to a packaging error; The kit does not contain the correct number of C1 or C2 control vials.

Packaging recalls include wrong labels, wrong products in the wrong bottle, missing leaflets, short-filled or empty capsules and seals that fail.

Product as listed by the FDA

VIDAS NT-pro-BNP Product Usage: VIDAS¿ NTproBNP (PBNP) is an automated quantitative test for use on the instruments of the VIDAS family for the determination of N terminal fragment of Btype natriuretic peptide in human serum or plasma (lithium heparin) using the ELFA technique (EnzymeLinked Fluorescent Assay). The VIDAS NTproBNP (PBNP) test is used as an aid in the diagnosis of suspected congestive heart failure.

Where it was distributed

US Nationwide Distribution in the states of: AL, AZ, CA, FL, GA, IA, KS, KY, MA, MI, MN, NC, NE, NJ, NY, OH, SC, TX, VA and WV.

Nationwide AlabamaArizonaCaliforniaFloridaGeorgiaIowaKansasKentuckyMassachusettsMichiganMinnesotaNorth CarolinaNebraskaNew JerseyNew YorkOhioSouth CarolinaTexasVirginiaWest Virginia

Questions about this recall

Why was it recalled?

Due to a packaging error; The kit does not contain the correct number of C1 or C2 control vials.

Which lots are affected?

Reference number: 30449-01, Lot #1004474560.

Where was it sold?

US Nationwide Distribution in the states of: AL, AZ, CA, FL, GA, IA, KS, KY, MA, MI, MN, NC, NE, NJ, NY, OH, SC, TX, VA and WV.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class III mean?

Class III recalls are for products unlikely to cause any adverse health consequence, usually labelling or quality issues.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Biomerieux France Chemin De L'Or

All 4

Other Test Kits & Diagnostics recalls

All 2,656